Side Effects of uridine triacetate: A Synthesis of Findings from 2 Studies
- Home
- Side Effects of uridine triacetate
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of uridine triacetate: A Synthesis of Findings from 2 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
A double-blind crossover study compared the hypnotic effect, daytime carryover, and safety of triazolam 0.5 mg, lorazepam 2 mg, and placebo. The two active drugs were similar in hypnotic effect and superior to placebo. Patients reported more drowsiness upon awakening and more sleepiness in mid-morning and mid-afternoon after nights on lorazepam than nights on triazolam or placebo. The most common side effects - drowsiness, lightheadedness, restlessness, impaired coordination, dizziness, and nausea - were reported three times as often with lorazepam than with triazolam or placebo. 1 .
5-fluorouracil (5FU) and capecitabine are fluoropyrimidine antineoplastic drugs commonly used in the treatment of different types of cancer. Hereditary dihydropyrimidine deaminase (DPD), thymidylate synthase mutations and drug overdose may lead to life-threatening toxicities. Uridine triacetate (UTA) is an emergency treatment for overdoses and early onset, severe or life-threatening toxicities from fluoropyrimidines. It is approved for use in adults and children within 96 h of last fluoropyrimidine administration. 2 . A case report describes a 64-year-old male treated with 5-FU and oxaliplatin as adjuvant systemic therapy for stage IIIA rectal cancer who developed delayed central nervous system toxicity 18 days after initiating chemotherapy. 2 . He had rapidly worsening encephalopathy and ataxia. Laboratory workups, MRI brain and EEG were negative. He was started on UTA with concerns of 5-FU toxicity due to the life-threatening nature of his condition even beyond the recommended 96-h time cut-off. 2 . He had rapid improvement in clinical status and resolution of encephalopathy. 2 . DPD deficiency testing later resulted as heterozygous for IVS14+1G>A allele indicating enzyme deficiency. 2 .
Reasons for side effects
Lorazepam has been reported to cause more side effects, such as drowsiness and lightheadedness, compared to triazolam or placebo, possibly due to its stronger central nervous system depressant effect compared to triazolam. 1 . 5-FU inhibits cell DNA synthesis and thereby inhibits cell proliferation and division, resulting in its anticancer effect. 2 . Toxicity of 5-FU is often caused by DPD enzyme deficiency or 5-FU overdose, and cytotoxicity through DNA synthesis inhibition is considered to cause side effects such as neurological toxicity. 2 .
Common side effects
Drowsiness
Patients reported more drowsiness upon awakening and more sleepiness in mid-morning and mid-afternoon after nights on lorazepam than nights on triazolam or placebo. 1 .
Lightheadedness
The most common side effects - drowsiness, lightheadedness, restlessness, impaired coordination, dizziness, and nausea - were reported three times as often with lorazepam than with triazolam or placebo. 1 .
Restlessness
The most common side effects - drowsiness, lightheadedness, restlessness, impaired coordination, dizziness, and nausea - were reported three times as often with lorazepam than with triazolam or placebo. 1 .
Impaired coordination
The most common side effects - drowsiness, lightheadedness, restlessness, impaired coordination, dizziness, and nausea - were reported three times as often with lorazepam than with triazolam or placebo. 1 .
Dizziness
The most common side effects - drowsiness, lightheadedness, restlessness, impaired coordination, dizziness, and nausea - were reported three times as often with lorazepam than with triazolam or placebo. 1 .
Nausea
The most common side effects - drowsiness, lightheadedness, restlessness, impaired coordination, dizziness, and nausea - were reported three times as often with lorazepam than with triazolam or placebo. 1 .
Encephalopathy
The patient exhibited rapidly worsening encephalopathy. 2 .
Ataxia
The patient exhibited ataxia. 2 .
Side effect management
Drowsiness
Avoid driving or operating dangerous machinery if you feel drowsy. 1 . Ensure adequate sleep time. 1 .
Lightheadedness
If you experience lightheadedness, exercise caution when standing up or walking. 1 . Consult your doctor if needed. 1 .
Restlessness
If you experience restlessness, try relaxation techniques or consult your doctor. 1 .
Impaired coordination
Avoid driving or operating dangerous machinery if you have impaired coordination. 1 .
Dizziness
If you experience dizziness, exercise caution when standing up or walking. 1 .
Nausea
You can be prescribed medication to suppress nausea. 1 .
Encephalopathy
If you suspect encephalopathy, seek immediate medical attention. 2 .
Ataxia
If you have ataxia, be careful to avoid falls. 2 . Consult your doctor if needed. 2 .
Comparison of Research
Commonalities
Both studies investigated different medications and reported side effects. 1 2 .
Differences
The study comparing triazolam and lorazepam reported more side effects like drowsiness from lorazepam. 1 . The study on 5-FU toxicity reported delayed neurological toxicity. 2 .
Considerations for Real-Life Application
Sleeping pills can cause side effects such as drowsiness. 1 . Exercise caution when driving or operating dangerous machinery. 1 . Anticancer drugs like 5-FU can cause serious side effects. 2 . It is crucial to take these medications as directed by your doctor. 2 .
Limitations of Current Research
The study comparing triazolam and lorazepam had a limited sample size, therefore further research with a larger sample is needed. 1 . The study on 5-FU toxicity was a case report, and more studies with a larger number of patients are required. 2 .
Future Research Directions
Research on the side effects of sleeping pills needs to investigate long-term effects. 1 . In research on 5-FU toxicity, identifying risk factors for side effects, such as DPD deficiency, is crucial. 2 .
Conclusion
Triazolam and lorazepam showed no difference in hypnotic effect, but lorazepam reported more side effects such as drowsiness compared to triazolam. 1 . 5-FU can cause serious side effects, including delayed neurological toxicity. 2 . It is important to obtain appropriate information, such as consulting your doctor, about the side effects of medications. 1 2 .
Article Type
Author: JacobAasems, Sekkath VeeduJaneesh, SeleneInsija, RajRishi, KannanLakshmi, PatelReema
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.